BiotechTube
Home/LinkGevity/Bill Davis
BD

Bill Davis

Chief R&D Officer

LinkGevity

Therapeutic Areas

AgingKidney DiseaseInflammatory Bowel DiseaseOncology

LinkGevity Pipeline

DrugIndicationPhase
LINK-001Kidney Disease (Acute Kidney Injury)Phase 2
LINKAgingPhase 2
Anti-Necrotics PlatformVarious (Tissue Engineering, Organ Preservation)Non-Clinical

Leadership Team at LinkGevity

DC
Dr. Carina Kern
Chief Executive Officer
SK
Serena Kern-Libera
Chief Operating Officer
GJ
Greg Jarzabek
Chief Financial Officer
LR
Lukasz Rzeczkowski
Chief Commercial Officer
NG
Nikodem Grzesiak
Chief Technology Officer
RL
Rafal Libera
Chief Growth Officer
View full LinkGevity profile